Literature DB >> 21926262

Clinical value of absolute quantification of myocardial perfusion with (15)O-water in coronary artery disease.

Sami A Kajander1, Esa Joutsiniemi, Markku Saraste, Mikko Pietilä, Heikki Ukkonen, Antti Saraste, Hannu T Sipilä, Mika Teräs, Maija Mäki, Juhani Airaksinen, Jaakko Hartiala, Juhani Knuuti.   

Abstract

BACKGROUND: The standard interpretation of perfusion imaging is based on the assessment of relative perfusion distribution. The limitations of that approach have been recognized in patients with multivessel disease and endothelial dysfunction. To date, however, no large clinical studies have investigated the value of measuring quantitative blood flow and compared that with relative uptake. METHODS AND
RESULTS: One hundred four patients with moderate (30%-70%) pretest likelihood of coronary artery disease (CAD) underwent PET imaging during adenosine stress using (15)O-water and dynamic imaging. Absolute myocardial blood flow was calculated from which both standard relative myocardial perfusion images and images scaled to a known absolute scale were produced. The patients and the regions then were classified as normal or abnormal and compared against the reference of conventional angiography with fractional flow reserve. In patient-based analysis, the positive predictive value, negative predictive value, and accuracy of absolute perfusion in the detection of any obstructive CAD were 86%, 97%, and 92%, respectively, with absolute quantification. The corresponding values with relative analysis were 61%, 83%, and 73%, respectively. In region-based analysis, the receiver operating characteristic curves confirmed that the absolute quantification was superior to relative assessment. In particular, the specificity and positive predictive value were low using just relative differences in flow. Only 9 of 24 patients with 3-vessel disease were correctly assessed using relative analysis.
CONCLUSIONS: The measurement of myocardial blood flow in absolute terms has a significant impact on the interpretation of myocardial perfusion. As expected, multivessel disease is more accurately detected.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21926262     DOI: 10.1161/CIRCIMAGING.110.960732

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  59 in total

Review 1.  PET measurement of adenosine stimulated absolute myocardial blood flow for physiological assessment of the coronary circulation.

Authors:  Henry Gewirtz
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

2.  Advances in clinical application of quantitative myocardial perfusion imaging.

Authors:  Juhani Knuuti; Antti Saraste
Journal:  J Nucl Cardiol       Date:  2012-08       Impact factor: 5.952

Review 3.  PET: Is myocardial flow quantification a clinical reality?

Authors:  Antti Saraste; Sami Kajander; Chunlei Han; Sergey V Nesterov; Juhani Knuuti
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

Review 4.  SPECT and PET in ischemic heart failure.

Authors:  George Angelidis; Gregory Giamouzis; Georgios Karagiannis; Javed Butler; Ioannis Tsougos; Varvara Valotassiou; George Giannakoulas; Nikolaos Dimakopoulos; Andrew Xanthopoulos; John Skoularigis; Filippos Triposkiadis; Panagiotis Georgoulias
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

Review 5.  Applications of PET-MR Imaging in Cardiovascular Disorders.

Authors:  Rhanderson Cardoso; Thorsten M Leucker
Journal:  PET Clin       Date:  2020-07-21

6.  SPECT but not PET remains as the working horse of the state of the art nuclear cardiac imaging laboratory: Con.

Authors:  Antti Saraste; Juhani Knuuti
Journal:  J Nucl Cardiol       Date:  2017-07-31       Impact factor: 5.952

Review 7.  Cardiac PET-CT for monitoring medical and interventional therapy in patients with CAD: PET alone versus hybrid PET-CT?

Authors:  Quynh A Truong; Henry Gewirtz
Journal:  Curr Cardiol Rep       Date:  2014-03       Impact factor: 2.931

Review 8.  CFR and FFR assessment with PET and CTA: strengths and limitations.

Authors:  Ryo Nakazato; Ran Heo; Jonathon Leipsic; James K Min
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

9.  Myocardial perfusion imaging with PET.

Authors:  Ryo Nakazato; Daniel S Berman; Erick Alexanderson; Piotr Slomka
Journal:  Imaging Med       Date:  2013-02-01

Review 10.  Automated Quantitative Nuclear Cardiology Methods.

Authors:  Manish Motwani; Daniel S Berman; Guido Germano; Piotr Slomka
Journal:  Cardiol Clin       Date:  2015-10-20       Impact factor: 2.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.